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Abstract Antibodies to blood-stage antigens of Plasmod-
ium falciparum play a pivotal role in human immunity to
malaria. During parasite development, multiple proteins
are trafficked from the intracellular parasite to the surface
of P. falciparum-infected erythrocytes (IEs). However, the
relative importance of different proteins as targets of
acquired antibodies, and key pathways involved in traf-
ficking major antigens remain to be clearly defined. We
quantified antibodies to surface antigens among children,
adults, and pregnant women from different malaria-ex-
posed regions. We quantified the importance of antigens as
antibody targets using genetically engineered P. falciparum
with modified surface antigen expression. Genetic deletion
of the trafficking protein skeleton-binding protein-1
(SBP1), which is involved in trafficking the surface antigen
PfEMP1, led to a dramatic reduction in antibody
recognition of IEs and the ability of human antibodies to
promote opsonic phagocytosis of IEs, a key mechanism of
parasite clearance. The great majority of antibody epitopes
on the IE surface were SBP1-dependent. This was
demonstrated using parasite isolates with different genetic
or phenotypic backgrounds, and among antibodies from
children, adults, and pregnant women in different popula-
tions. Comparisons of antibody reactivity to parasite
isolates with SBP1 deletion or inhibited PfEMP1 expres-
sion suggest that PfEMP1 is the dominant target of
acquired human antibodies, and that other P. falciparum IE
surface proteins are minor targets. These results establish
SBP1 as part of a critical pathway for the trafficking of
major surface antigens targeted by human immunity, and
have key implications for vaccine development, and
quantifying immunity in populations.
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Introduction
Malaria caused by Plasmodium falciparum remains a major
cause of morbidity and mortality worldwide [1]. Clinical
symptoms result from the blood-stage replication of the
parasite, which multiplies within erythrocytes. After ery-
throcyte invasion by the merozoite form, the
intraerythrocytic parasite undergoes development through
ring, trophozoite and schizont stages before rupturing to
release merozoites to perpetuate the asexual cycle. P. fal-
ciparum-induced modifications of infected erythrocytes
(IEs) (reviewed in [2, 3]) include the appearance of knob
structures on the IE membrane, created by the deposition of
knob-associated histidine-rich protein (KAHRP) molecules
on the cytoplasmic face of the erythrocyte membrane. These
knob structures enable the adhesion of IEs to vascular
receptors and sequestration of IEs to prevent clearance by
the spleen. Plasmodium falciparum erythrocyte membrane
protein 1 (PfEMP1), which is presented on the IE surface by
the knob structures, is a key ligand for IE sequestration in the
vasculature [4], and is not found other human malaria spe-
cies. A central feature in the pathogenesis of P. falciparum
malaria is the sequestration of IEs in the vasculature of
various organs, which is not prominent in other human
malarias such as P. vivax, P. knowlesi, P. ovale, P. malariae.
Plasmodium falciparum IE surface antigens are impor-
tant targets of acquired antibodies that contribute to
immunity and function by opsonizing IEs for phagocytic
clearance by monocytes, macrophages and other cells, and
by inhibiting vascular adhesion and rosette formation (re-
viewed in [5]). These antigens are polymorphic, and
antibodies that are acquired after exposure to infection
show a degree of strain specificity [6, 7]. Antibodies to IE
surface antigens have been associated with protection in
longitudinal studies (reviewed in [5]) and effective
immunity is thought to require the acquisition of a broad
repertoire of antibodies to different P. falciparum strains or
variants [6, 8]. Efforts to define the nature and importance
of IE surface antigens and to quantify which antigens are
targeted by naturally acquired immunity have been chal-
lenging due to the many IE surface proteins identified, the
complexity of multigene families encoding these antigens,
and limited tools available. In addition to PfEMP1, other
antigens identified on the IE surface include repetitive
interspersed family proteins (RIFIN) [9], subtelomeric
variable open reading frame proteins (STEVOR) [10–12],
surface-associated interspersed gene family proteins
(SURFIN) [13, 14] and others. These proteins are encoded
by multigene families with variation in expression between
isolates, which has presented many challenges to studying
them as immune targets. Recent approaches to study
immune responses using genetically modified parasites, in
a Kenyan coastal population, identified PfEMP1 as a major
target of acquired human antibodies [15]. However, the
relative importance of PfEMP1 and the significance of
other IE surface proteins remain unclear.
The trafficking of antigens to the IE surface is only
partly understood, and further detailed knowledge is
important for defining and quantifying key targets of pro-
tective immunity. Since erythrocytes are devoid of protein
trafficking machinery and de novo protein synthesis, P.
falciparum has to synthesize and export parasite proteins
for trafficking, as well as for parasite development (re-
viewed in [16]). Several P. falciparum proteins are
exported into the host erythrocyte to support the correct
trafficking and surface display of proteins in the erythro-
cyte membrane (reviewed in [2, 5]). The export of
PfEMP1, and other IE surface proteins, is highly complex
due to their large size, the number of membranes that must
be traversed before reaching the IE surface and the
involvement of various chaperone proteins (reviewed in
[16–18]). Skeleton-binding protein 1 (SBP1) [19] is an
important protein of membranous structures in the IE
cytosol called Maurer’s clefts (MC) and is required for the
loading of PfEMP1 molecules into the MC [20, 21].
Although the role of SBP1 in trafficking PfEMP1 has been
established, its role in trafficking other IE surface antigens
or membrane-bound proteins is unclear. Orthologues of
SBP1 have not yet been reported in other Plasmodium
species causing human malaria, but has been identified in
the chimpanzee malaria, P. reichenowi, which is a close
relative of P. falciparum and also expresses PfEMP1
orthologues [20–22]. This suggests that SBP1 has evolved
to export PfEMP1 and possibly other IE surface antigens in
P. falciparum, and its relative, P. reichenowi [20, 21].
Transcription of pfsbp1 commences shortly after erythro-
cyte invasion and persists throughout parasite development
[19]. SBP1 is a type 2 integral membrane protein (48 kDa)
with the N-terminal domain buried within the MC and the
C-terminus exposed within the IE cytoplasm where it
interacts with erythrocyte proteins such as LANCL1,
spectrin and protein 4.1 [19, 23, 24].
In this study, we aimed to quantify the importance of
SBP1 in the trafficking of IE surface antigens that are
important targets of protective immunity in P. falciparum
and evaluate the importance of PfEMP1 and other IE surface
antigens as targets of naturally acquired antibodies, includ-
ing functional antibodies that mediate the opsonic
phagocytosis of IEs, which is an important mechanism for
clearance of infection [25, 26]. These aims were achieved by
using parasites with a targeted deletion of pfsbp1 or genet-
ically engineered to inhibit var gene and PfEMP1 expression
and evaluating antibodies to parental parasites compared to
genetically modified parasites. We applied these tools to
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human studies in Kenya, Malawi and Papua New Guinea
(PNG), and included serum samples from children, adults
and pregnant women to represent the spectrum of malaria
exposure and immunity observed globally.
Results
Generation and characterization of P. falciparum
with SBP1 deletion
Isolates 3D7 SBP1KO (SBP1 ‘knock-out’) and CS2
SBP1KO have been previously generated and characterized
[20, 21]; the transport of PfEMP1 is arrested at MCs or the
parasitophorous vacuole, knob formation occurs normally,
but IE adhesion by SBP1KO was substantially reduced [20,
21]. In this study, we generated an additional parasite isolate,
E8B SBP1KO. E8B parental [27], repeatedly selected for
adhesion to immobilized intercellular adhesion molecule-1
(ICAM-1), was transfected with the pHHT-TK-DSBP1
plasmid and human-dihydrofolate reductase (DHFR) cas-
sette [20], which encodes resistance to WR99210, and then
cycled for integration. Southern blot analyses of the pfsbp1
locus in E8B showed the predicted band sizes of the parental
and disrupted loci containing the WR99210 resistance gene
hDHFR inserted by double crossover recombination
(Fig. 1a). Western blot analyses of IE membrane extracts
from pigmented trophozoites confirmed the loss of SBP1 in
E8B SBP1KO compared to E8B parental which had a band
at approximately 50 kDa (Fig. 1b). Northern blot analysis
showed the active transcription of var genes in E8B
SBP1KO that were of similar size to E8B parental (Fig. 1c),
which suggests that there has not been a switch in var gene
expression, consistent with previous findings with SBP1KO
parasites [20]. Pigmented trophozoites of E8B SBP1KO had
markedly reduced adhesion, with almost no binding to
immobilized ICAM-1 (Fig. 1d) and CD36 (Fig. 1e), con-
sistent with the loss of PfEMP1 surface expression. It was
shown in previous studies, with repeated failure to select
SBP1KO parasites for cytoadhesion, that this phenotype is
not due to var gene switching [20].
To further characterize the different SBP1KO parasites,
it was important to investigate whether the deletion of
pfsbp1 had affected the trafficking and expression of other
IE membrane proteins. 3D7 SBP1KO and CS2 SBP1KO
were previously reported to retain the typical expression of
knobs similar to parental parasites, suggesting that KAHRP
expression was unaffected [20, 21]. Here, scanning elec-
tron microscopy of pigmented trophozoite-IEs confirmed
the expression of knobs by E8B SBP1KO similar to those
of E8B parental (Fig. 2a). Additionally, RIFIN and STE-
VOR proteins localized to the IE membrane remain
expressed by both E8B SBP1KO (Fig. 2) and 3D7
SBP1KO (Supplemental Fig S1), similar to their respective
parental parasites. Immunofluorescence microscopy with
anti-RIF40 antibodies labeled the IE membrane of E8B
(Fig. 2b) and 3D7 mature trophozoites (Supplemental Fig
S1A). Anti-STEVOR10 antibodies also labeled the IE
membrane of mature trophozoites from E8B parental and
SBP1KO (Fig. 2c) and 3D7 parental and SBP1KO isolates
(Supplemental Fig S1B) by immunofluorescence micro-
scopy. There was no labeling of uninfected erythrocytes by
anti-RIF40 or anti-STEVOR10 antibodies and cells were
fixed prior to antibody incubations. Furthermore, anti-
RIF29 and anti-STEVOR3 antibodies labeled proteins of
expected molecular size (*30–40 kDa) in Western blots
of IE membrane extracts from E8B (Fig. 2d) and 3D7
mature trophozoites (Supplemental Fig S1C). Immunoflu-
orescence microscopy also confirmed that another IE
membrane protein, PfEMP3, remained expressed by E8B
SBP1KO (Fig. 2e) and 3D7 SBP1KO (Supplemental Fig
S1D), similar to parental parasites. We obtained further
evidence that RIFINs remain exposed on the IE surface of
the SBP1KO parasites. We examined degradation of
RIFINs following treatment of intact IEs with high con-
centrations of trypsin (1 mg/ml for 30 min), which has
been reported to cleave RIFINs [28–30]. Western blotting
of IE extracts from pigmented trophozoites with anti-
RIF40.2 antibodies demonstrated that trypsin treatment of
intact 3D7 parental and 3D7 SBP1KO IEs led to a reduc-
tion in the labeling of RIFINs, consistent with the cleavage
of RIFINs on the IE surface by trypsin (Fig. 2f). Similarly,
trypsin treatment of intact E8B parental and E8B SBP1KO
led to a reduction of RIFINs labeled on western blots,
suggesting cleavage of surface-exposed RIFIN proteins
(Fig. 2f). These findings suggest that the trafficking and
expression of several IE membrane proteins other than
PfEMP1 occurred normally in the SBP1KO parasites.
Antibodies to the IE surface predominantly target
antigens dependent on SBP1 for trafficking
To understand the significance of SBP1 in the trafficking of
IE surface antigens that are targeted by naturally acquired
antibodies, samples from malaria-exposed individuals were
measured by an established flow cytometry-based assay
[15] against parental and SBP1KO parasites. The levels of
acquired antibodies targeting native antigens expressed on
the IE surface were quantified.
Papua New Guinea (PNG)
We tested a selection of serum samples (n = 87) from
malaria-exposed adults (n = 46) and children (n = 41)
residing in Madang, PNG for antibodies to the surface of
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erythrocytes infected with 3D7 parental and 3D7 SBP1KO
parasites. The overall IgG binding to 3D7 SBP1KO was
substantially reduced compared to 3D7 parental (Fig. 3a;
p\ 0.0001). Sera from most individuals showed a marked
reduction in IgG binding to 3D7 SBP1KO compared to
3D7 parental (Fig. 3b). Of those samples that were con-
sidered positive for IgG binding (defined as antibody levels
greater than mean ? 3SD of negative controls) to 3D7
parental (81/87; 93.1 %), there was an 85.6 % reduction in
median IgG binding to 3D7 SBP1KO (p = 0.01), sug-
gesting that most antibodies are directed at SBP1-
dependent antigens expressed on the IE surface (reflected
by the level of IgG binding to 3D7 parental minus 3D7
SBP1KO). To further understand the role of SBP1 in the
transport of IE surface antigens, we used the genetically
different parasite isolate, E8B. A selection of plasma
samples (n = 91) from the same PNG cohort of adults
(n = 50) and children (n = 41) were tested for antibodies
to the surface of erythrocytes infected with E8B parental
and E8B SBP1KO parasites. The overall IgG binding to
E8B SBP1KO was greatly reduced compared to E8B par-
ental (Fig. 3c; p\ 0.0001). Most plasma samples showed a
substantial decrease in IgG binding to E8B SBP1KO
(Fig. 3d). Of those samples that were considered positive
for IgG binding to E8B parental (72/91; 79.1 %), there was
a 61.3 % reduction in median antibody reactivity to E8B
SBP1KO (p = 0.001), further indicating that the majority
of the antibody response in this cohort was directed
towards IE surface antigens that are dependent on SBP1 for
trafficking.
Antibody levels to 3D7 parental in adults and children
from PNG were largely similar (Supplemental Fig S2A;
p = 0.15), suggesting that antibodies to IE surface antigens
of 3D7 were acquired at a relatively young age in this
population. IgG binding to 3D7 SBP1KO was markedly
reduced compared to 3D7 parental for both adults
(p\ 0.0001) and children (p\ 0.0001) (Supplemental Fig
S2B), indicating that antibodies targeting SBP1-dependent
antigens on the IE surface are highly prevalent in both
groups. Adults had markedly higher IgG levels than chil-
dren to E8B parasites (Supplemental Fig S2C;
p = 0.0004). Similar to 3D7, IgG binding to E8B SBP1KO
was substantially reduced compared to E8B parental for
both adults (p\ 0.0001) and children (p\ 0.0001) (Sup-
plemental Fig S2D). These results further indicate that
naturally acquired human antibodies to the IE surface are
primarily directed towards SBP1-dependent antigens,
among children and adults.
bFig. 1 Phenotypic analyses of pfsbp1 knock-out (SBP1KO) parasites.
a Southern blot analysis of the pfsbp1 locus in E8B parental and E8B
SBP1KO parasites. Genomic DNA was digested with EcoRI/Bgl II
and probed with the 50 or 30 targeting sequence. Predicted sizes for the
plasmid were 6.9 kb (for both 50 and 30 probes) and 4.6 kb for E8B
parental (for both 50 and 30 probes); predicted sizes for E8B SBP1KO
were 2.7 kb (for 50 probe) and 1.1 kb (for 30 probe). b Western blot
analyses of membrane extracts from mature trophozoite IEs probed
with a-SBP1 antibodies. Antibodies detected SBP1 at approximately
50 kDa (arrow) in E8B parental, E8Bvpkd (PfEMP1 knock-down)
and E8B-ICAM1 (parental line selected on ICAM1), which was
absent in E8B SBP1KO. The band at 100 kDa present in all lanes
corresponds to antibody cross reactivity. c Northern blot analysis of
var gene transcription by hybridization with a specific var exon 2
sequence. The position of molecular weight standards (kb) is
indicated on the left and the arrow represents var transcripts. In both
E8B parental and E8B SBP1KO parasites, similar var transcripts were
detected. RNA was extracted from highly synchronous ring stage IEs
at approximately 10 h post-invasion. Adhesion of IEs to immobilized
ICAM-1 (d) and CD36 (e) was substantially reduced in E8B SBP1KO
compared to E8B parental. Values are expressed as a percentage of
parental parasites binding to ICAM-1 or CD36. Assays were
performed twice independently and bars represent median and
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Kenya
To expand these findings in a geographically different
population, serum samples (n = 26) from a selection of
adults (n = 5) and children (n = 21) residing in Chonyi,
Kenya were tested for antibodies to the surface of ery-
throcytes infected with 3D7 parental and 3D7 SBP1KO
parasites. The overall IgG binding to 3D7 SBP1KO was
substantially reduced compared to 3D7 parental (Fig. 4a;
p\ 0.0001). Most individuals showed a marked reduction
in IgG binding to 3D7 SBP1KO (Fig. 4b). All 26 samples
were classified as positive for IgG binding to 3D7 parental
and there was a 90 % reduction in median antibody reac-
tivity to 3D7 SBP1KO (p = 0.0002). Serum samples
(n = 15) from adults residing in Kilifi, Kenya were also
tested for antibodies to the surface of erythrocytes infected
with E8B parental and E8B SBP1KO. The overall IgG
reactivity to E8B SBP1KO was markedly reduced com-
pared to E8B parental (Fig. 4c) (p = 0.01). Sera from most
individuals showed a substantial reduction in IgG binding
to E8B SBP1KO (Fig. 4d). All 15 samples were classified
as positive for IgG binding to E8B parental and there was a
81.9 % reduction in median antibody reactivity to E8B
SBP1KO (p = 0.15), suggesting that SBP1 is crucial for
the trafficking of major antibody targets.
Antibodies to pregnancy-associated surface antigens
predominantly target SBP1-dependent antigens
Pregnant women are an additional group at high risk of
malaria and are infected with specific P. falciparum vari-
ants that evade existing immunity and sequester in the
placenta [31, 32]. Serum samples (n = 94) from a cohort
of pregnant women residing in PNG were tested for anti-
bodies to the IE surface of the placental-binding isolate
CS2 parental and CS2 SBP1KO. This isolate expresses
VAR2CSA, a PfEMP1 variant that mediates adhesion to
CSA in the placenta [33]. The overall IgG binding to CS2
SBP1KO was substantially reduced (90 %) compared to
CS2 parental (Fig. 5a; p\ 0.0001). Most individuals
showed a marked reduction in IgG binding to CS2
SBP1KO (Fig. 5b). When classified according to gravidity,
the majority of samples tested from primigravid (PG;
n = 33) and multigravid (MG; n = 30) women showed a
marked decrease in antibody response to CS2 SBP1KO
compared to CS2 parental (Fig. 5c); 19/33 samples
(57.6 %) from PG women were positive for IgG binding to
CS2 parental and 12/33 samples (36.4 %) were positive for
IgG binding to CS2 SBP1KO (p = 0.09); 23/30 samples
(76.7 %) and 15/30 samples (50 %) from MG women were
positive for IgG binding to CS2 parental and CS2
SBP1KO, respectively (p = 0.05). Of those samples that
were considered positive for IgG binding to CS2 parental,
IgG binding to CS2 SBP1KO was reduced by 83.1 % in PG
women and 91.2 % in MG women. As expected, the level
of antibodies was substantially higher in MG women than
PG women (Fig. 5c), consistent with previous reports [31,
34]. The level and prevalence of antibodies to CS2 para-
sites were substantially lower in men compared to pregnant
women (Fig. 5c); 9/31 samples (29 %) from men were
classified as positive for IgG binding to CS2 parental
whereas none of the samples were classified as positive for
IgG binding to CS2 SBP1KO (p = 0.001).
We confirmed these findings with serum samples from a
cohort of pregnant women (n = 71) and men (n = 10)
residing in Malawi. Again, overall IgG binding to CS2
SBP1KO was substantially reduced (76.7 %) compared to
CS2 parental (Fig. 5e; p\ 0.0001). Most individuals
showed a marked reduction in IgG binding to CS2
SBP1KO (Fig. 5f). When classified according to gravidity,
the majority of samples tested from primigravid (PG;
n = 35) and multigravid (MG; n = 36) women showed a
marked decrease in antibody response to CS2 SBP1KO
compared to CS2 parental (Supplemental Fig S3A); 22/35
samples (62.9 %) from PG women were positive to CS2
parental and 20/35 samples (57.1 %) were positive to CS2
SBP1KO (p = 0.73); 22/36 samples (61.1 %) from MG
women were positive for IgG to CS2 parental while 6/36
samples (16.7 %) were positive for CS2 SBP1KO
(p = 0.001). The overall IgG binding to CS2 SBP1KO in
samples from men residing in the same region was mark-
edly reduced compared to CS2 parental (Supplemental Fig
S3A; p = 0.002). The level and prevalence of antibodies to
CS2 parasites were substantially lower in men compared to
pregnant women (Supplemental Fig S3A).
To confirm the loss of VAR2CSA-PfEMP1 expression
in CS2 SBP1KO, we tested rabbit antibodies raised against
the DBL3 domain of VAR2CSA expressed by CS2 [35] for
recognition of the IE surface of CS2 parental and CS2
SBP1KO parasites. There was markedly lower IgG binding
to CS2 SBP1KO (Fig. 5d), suggesting the absence of
PfEMP1 on the IE surface of these parasites and supporting
the significance of SBP1 in the trafficking of PfEMP1.
Antibodies that mediate opsonic phagocytosis of IEs
predominantly target SBP1-dependent antigens
on the IE surface
To examine the importance of SBP1 in the trafficking of IE
surface antigens targeted by functional antibodies, serum
samples from Kenyan adults were tested for their ability to
opsonize pigmented trophozoite-IEs for phagocytic clear-
ance by undifferentiated Thp-1 monocytes, an established
model of opsonic phagocytosis [15, 36, 37]. IEs were
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incubated with serum samples for opsonisation by anti-
bodies before co-incubation with THP-1 monocytes was
performed to test for phagocytosis. The ability of serum
antibodies (n = 25) to promote opsonic phagocytosis
activity was substantially reduced (78.4 %) in 3D7
SBP1KO compared to 3D7 parental (Fig. 6a; p\ 0.0001).
We also tested serum IgG purified from these Kenyan
adults (n = 9) for their opsonic phagocytosis activity with
E8B parental and E8B SBP1KO. The level of opsonic
phagocytosis was markedly reduced by 77.1 % in E8B
SBP1KO compared to E8B parental (Fig. 6c; p = 0.0001).
All samples showed a reduction in opsonic phagocytosis
activity to 3D7 SBP1KO (Fig. 6b) and E8B SBP1KO
(Fig. 6d) compared to their respective parental parasites.
Furthermore, we tested a selection of plasma samples
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PNG for their opsonic phagocytosis activity. Similarly, the
ability of serum antibodies to opsonize IEs for phagocy-
tosis was substantially reduced (60.8 %) in E8B SBP1KO
compared to E8B parental (Fig. 6e; p\ 0.0001) and all
samples showed a reduction in opsonic phagocytosis
activity to E8B SBP1KO (Fig. 6f) compared to E8B par-
ental. Together, our results suggest that antibodies target
SBP1-dependent antigens on the IE surface function to
opsonise IEs for phagocytosis.
We tested serum samples from pregnant women
(n = 36) residing in Malawi for their opsonic phagocytosis
activity to CS2 parental and CS2 SBP1KO parasites. The
ability of serum antibodies to promote opsonic phagocy-
tosis activity was substantially reduced (76.4 %) in CS2
SBP1KO compared to CS2 parental (Fig. 7a; p\ 0.0001).
All samples showed a reduction in opsonic phagocytosis
activity to CS2 SBP1KO (Fig. 7b) compared to their
respective parental parasites, suggesting the functional
importance of antibodies to SBP1-dependent antigens.
PfEMP1 is the major target of antibodies to the IE
surface
To investigate the identity of SBP1-dependent antigens
recognized by human antibodies we used P. falciparum
that was genetically engineered to suppress PfEMP1
expression (var promoter knock-down, vpkd). These
parasites, which have been previously described and
characterized in detail, have inhibited PfEMP1 surface
expression through the suppression of endogenous var
genes [15, 38]. Antibody levels to the surface of pig-
mented trophozoite-IEs were compared between parental,
vpkd and SBP1KO parasites. In a selection of PNG
individuals (n = 12), the overall IgG reactivity to
E8Bvpkd and E8B SBP1KO was substantially lower than
parental E8B. Reactivity to E8B SBP1KO was lower
again than to E8Bvpkd (Fig. 8a; p = 0.008). Compared
to E8B parental, IgG binding was reduced by 54.5 % to
E8Bvpkd and by 76.5 % to E8B SBP1KO. The majority
of the samples showed a marked reduction in IgG
binding to E8B SBP1KO compared to E8Bvpkd and
E8B parental (Fig. 8b). Similar results were seen using
adult sera from Kilifi, Kenya (n = 7). (Figure 8c, d;
p = 0.02). Compared to E8B parental, IgG binding was
reduced by 79.3 % to E8Bvpkd and by 91.6 % to E8B
SBP1KO. Similar results were also seen using 3D7
parental, vpkd and SBP1KO parasites (Supplemental Fig
S4). For PNG serum (n = 81) IgG binding was reduced
by 79.5 % to 3D7vpkd and by 89 % to 3D7 SBP1KO
compared to parental 3D7 (Supplemental Fig S4A, S4B).
For samples from Kenya, IgG binding was reduced by
76.7 % to 3D7vpkd and by 90 % to 3D7 SBP1KO
compared to 3D7 parental (Supplemental Fig S4C, S4D).
This suggests that most of the SBP1-dependent antibody
targets are PfEMP1.
To understand the nature of residual antibody reactivity
to vpkd IEs, compared to SBP1KO IEs, we evaluated the
effect of trypsin treatment of IEs on antibody binding
(Fig. 8e). The majority of IgG binding to 3D7 parental
surface antigens was highly trypsin sensitive, suggesting
that antibodies are targeting PfEMP1 on the IE surface,
since PfEMP1 is known to be trypsin sensitive [4]. The
residual IgG binding observed with 3D7vpkd parasites was
also trypsin sensitive, consistent with PfEMP1 being the
target of these antibodies. Treatment of 3D7vpkd with
trypsin reduced antibody reactivity to levels that were
comparable to 3D7 SBP1KO, suggesting that antibody
reactivity to 3D7vpkd may represent residual PfEMP1
expression.
bFig. 2 Ultrastructural features of the IE membrane and expression of
IE membrane proteins by E8B parasites. a Scanning electron
microscopy confirmed the expression of surface knob protrusions
(arrows) with IEs from E8B SBP1KO similar to that of E8B parental.
Representative images are shown and scale bar represents 2 lm in all
images. Labeling of RIFIN (b) and STEVOR (c) proteins expressed
by pigmented trophozoite-IEs were visualized by immunofluores-
cence microscopy using specific a-RIF40 and a-STEVOR10
antibodies (green). Despite the lack of PfEMP1 expression, RIFIN
and STEVOR were detected in E8B SBP1KO (lower panel), similar
to E8B parental (upper panel). The pattern of staining was consistent
with the reported labeling of RIFIN and STEVOR in the IE
membrane. d Western blot analyses of pigmented trophozoite-IEs
membrane extracts probed with a-RIF29 (left) and a-STEVOR3
(right) antibodies, which detected RIFIN and STEVOR in both E8B
parental and E8B SBP1KO parasites. Equal loading of parasite
material was confirmed with a-HSP70 antibodies (bottom panel).
e Pigmented trophozoite-IEs of E8B parental and E8B SBP1KO were
probed with a-PfEMP3 antibodies (first column) as a positive control
and a-AMA1 antibodies (second column) as a negative control
(antibody staining in green, DAPI staining in blue). As expected, the
pattern of staining was consistent with the labeling of PfEMP3 in the
IE membrane and there was no apparent labeling by anti-AMA1. In
all immunofluorescence assays, cells were fixed with a mixture of
acetone (90 %) and methanol (10 %) and DAPI was used to stain
nuclear DNA (blue). All images were taken at equal exposure for both
parasite lines and representative images are shown. f Western blot
analyses of protein extracts from purified pigmented trophozoite-IEs
(parental and SBP1KO) that were treated with trypsin (?) or control
(-). Blots were probed with a-RIF40.2, a-aldolase and a-SBP1 for
3D7 (left) and E8B (right) parasites. There was a reduction in the
labeling of RIFINs after trypsin treatment of live IEs. Equal loading
of parasite material was confirmed with a-aldolase. a-SBP1 con-
firmed the absence of SBP1 protein in the SBP1KO parasites and
showed that the erythrocyte plasma membrane remained intact during
trypsin treatment
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Discussion
Our findings indicate that, remarkably, a single parasite
protein, SBP1, is required for the transport of IE surface
antigens that are the major targets of human antibodies
against P. falciparum infections. SBP1 is clearly a crucial
component of the trafficking pathway for surface antigens
and may represent an important difference between P. fal-
ciparum and other human malaria species. Comparing the
level of IgG binding to the IE surface between parental and
SBP1KO allowed the quantification of antibodies targeting
SBP1-dependent antigens and defined a key property of
major surface antigens and epitopes. The overall IgG bind-
ing to SBP1KO IEs was dramatically reduced compared to
parental parasites, indicating that the great majority of the
naturally acquired antibodies to the IE surface targeted
SBP1-dependent antigens. The decrease in antibody reac-
tivity to SBP1KO parasites was observed with serum
antibodies from children and adults from PNG andKenya, as
well as serum antibodies from pregnant women residing in
PNG and Malawi. Furthermore, the level of functional
antibodies measured through opsonic phagocytosis activity
was greatly reduced in the SBP1KO parasites. Comparisons
between antibody reactivity to SBP1KO and PfEMP1
knock-down (vpkd) parasites supported the conclusion that
PfEMP1 is the dominant target of human antibodies.
Plasmodium falciparum malaria affects children, adults


















































































































Fig. 3 Antibodies among children and adults from PNG to surface
antigens expressed by P. falciparum-IEs. IgG binding to the surface
of erythrocytes infected with 3D7 SBP1KO (a), E8B SBP1KO (c) and
was markedly reduced compared to 3D7 parental and E8B parental
parasites, respectively. Assays were performed twice independently;
bars represent median and interquartile ranges of samples tested in
duplicate (n = 87 for 3D7, n = 91 for E8B); p value was calculated
using a paired Wilcoxon signed rank test; IgG binding levels are
expressed as geometric mean fluorescence intensity (MFI) for all
graphs. A representative selection of serum samples from PNG tested
for antibodies to 3D7 SBP1KO (b) and E8B SBP1KO (d). Samples
were from malaria-exposed children and adults (P3-P25) (b and
d) and non-exposed Melbourne residents (Control). IgG binding to
3D7 SBP1KO and E8B SBP1KO was substantially reduced in most
individuals, with adults having a higher proportion of antibody
response. There was minimal background reactivity observed among
sera from Melbourne residents. Assays were performed twice
independently; bars represent mean and range of samples tested in
duplicate
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many parts of Africa, Asia, South America and the Pacific.
Plasmodium falciparum exposure and the development of
naturally acquired immunity can vary considerably
between risk groups and geographical regions. Therefore,
to ensure generalizability of findings we included samples
from all three risk groups (children, adults, pregnant
women) that represented different populations from Africa
(Kenya and Malawi) and other regions (PNG). Addition-
ally, we used three different parasite isolates, with different
genetic or phenotypic backgrounds. Prior studies have
shown that parasite isolates such as 3D7 and IT4 lines
(E8B) are commonly recognized by serum from malaria-
exposed individuals across different geographic regions
[27, 39, 40]. Strikingly, the same pattern of substantially
reduced antibody binding to SBP1KO parasites was
observed in all risk groups and populations with each of
our three P. falciparum isolates. These repeated observa-
tions provide strong evidence for SBP1-dependent IE
surface antigens being predominant antibody targets with
minimal targeting of non-SBP1-dependent antigens by
human immune responses.
The functional mechanisms of antibodies to IE surface
antigens that protect against malaria are not fully under-
stood. Antibodies are believed to contribute to protection
against symptomatic disease by opsonising IEs for clear-
ance by monocytes or macrophages [25, 26, 41].
Undifferentiated THP-1 monocytes were used in this study
because they specifically measure Fc-mediated opsonic
phagocytosis and have very little non-opsonic phagocytosis
[36]. Antibody-mediated opsonic phagocytosis was greatly
reduced in 3D7 SBP1KO, E8B SBP1KO and CS2













































































































Fig. 4 Antibodies among Kenyan individuals to surface antigens
expressed by P. falciparum-IEs. IgG binding to the surface of
erythrocytes infected with 3D7 SBP1KO (a) and E8B SBP1KO
(c) was markedly reduced compared to 3D7 parental and E8B
parental. Assays were performed twice independently; bars represent
median and interquartile ranges of samples tested in duplicate
(n = 26 for 3D7, n = 15 for E8B); p value was calculated using a
paired Wilcoxon signed rank test; IgG binding levels are expressed as
geometric mean fluorescence intensity (MFI) for all graphs. A
representative selection of serum samples tested for antibodies to 3D7
SBP1KO (b) and E8B SBP1KO (d). Samples were from malaria-
exposed individuals residing in Kenya (C3–C25; K2–K11) and non-
exposed Melbourne residents (control). IgG binding to 3D7 SBP1KO
and E8B SBP1KO was substantially reduced in most individuals.
There was minimal background reactivity observed among sera from
Melbourne residents. Assays were performed twice independently;
bars represent mean and range of samples tested in duplicate
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parasites, providing key evidence that antibodies to SBP1-
dependent epitopes on the IE surface function in the
opsonic phagocytosis of IEs. It was interesting that some
measurable opsonic phagocytosis activity was still detected
in the SBP1KO parasites. Although it was low, it may still
contribute to immunity and could potentially be accounted
for by antibodies to other IE surface antigens such as
RIFIN and STEVOR, which are still expressed by the
SBP1KO parasites. An additional important mechanism
that is thought to contribute to immunity is antibody inhi-
bition of IE adhesion or rosetting (reviewed in [5]). For
example, antibodies from pregnant women sera inhibited
the binding of IEs to the placental receptor CSA [34, 42],
which have been associated with reduced malaria in
pregnancy and placental infection [42, 43]. Furthermore,
antibodies from children with mild malaria disrupted
rosette formation whereas those with severe malaria did
not, suggesting that acquired antibodies mediate protection
through inhibition of rosette formation [44, 45]. In our
study, and previous studies, we show that disruption of
SBP1 leads to loss of cytoadhesion ability and antibody
recognition, suggesting that antibodies that inhibit adhesion
are targeting SBP1-dependent antigens, particularly
PfEMP1. IE surface antigens also have other important
immune interactions, such as cellular immunity. Prior
studies have reported that PfEMP1 may impact on
responses by a range of cell types, including dendritic cells,
T cells, and innate immune cells [46–50]. Future studies
using SBP1KO parasites to better understand these
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PfEMP1 and other surface antigens in cell-mediated
immunity.
Antibodies directed to the IE surface of P. falciparum
isolates that are prevalent in pregnancy malaria also rep-
resent important components of protective immunity [42].
These antibodies are thought to confer protection by
inhibiting parasite sequestration in the placenta [31, 42, 51]
and promoting the opsonic phagocytosis of IEs [52–54].
The PfEMP1 variant, VAR2CSA, is an important antibody
target and vaccine candidate but other antigens have also
been proposed [55]. Reflecting previous exposure to CSA-
binding isolates that primarily expresses var2csa [56],
multigravid (MG) women generally have a higher preva-
lence of antibodies to placental isolates compared to
primigravid (PG) women or men [31, 34, 57] and the
findings in this study are consistent with that. IgG binding
to CS2 SBP1KO in both PG and MG women was markedly
reduced compared to CS2 parental, demonstrating that
surface antigens dependent on SBP1 are major targets of
acquired antibodies, a substantial proportion of which is
presumably directed at VAR2CSA. In our study, rabbit
antibodies raised against VAR2CSA were used to confirm
the loss of PfEMP1 surface expression in the CS2 SBP1KO
parasites.
The importance of PfEMP1 as a target was demon-
strated by comparing the levels of IgG binding between
parental, vpkd and SBP1KO parasites. The majority of the
loss of reactivity of antibodies to SBP1KO parasites could
be explained by a loss of PfEMP1, supporting the con-
clusion that PfEMP1 is the major target of human
antibodies to the IE surface. Interestingly, there was a small
further reduction in antibody reactivity to SBP1KO com-
pared to vpkd parasites. This was observed in E8B and 3D7
parasites, and similarly for both PNG and Kenyan popu-
lations. The residual antibody binding to vpkd compared to
SBP1KO might reflect residual PfEMP1 expression in the
vpkd parasites, whereas SBP1KO may have inhibited
PfEMP1 surface display more efficiently. Reactivity to
3D7vpkd was largely trypsin sensitive, similar to the sen-
sitivity pattern of 3D7 parental parasites, suggesting that
the reactivity may be explained by residual PfEMP1
expression on vpkd parasites. PfEMP1 has been described
as being highly sensitive to trypsin treatment [4] compared
to other antigens such as RIFIN, that have been reported to
be resistant to cleavage by low trypsin concentrations [28,
29].
The low antibody reactivity to SBP1KO parasites sug-
gests that antibodies that may target other antigens that are
trafficked to the IE surface independent of SBP1 expression
are not a prominent feature of the naturally acquired
immune response. Possible antigens include RIFIN, STE-
VOR or SURFIN families which have been previously
identified on the IE surface [12, 13, 28–30, 58, 59]. We
found that that the expression of other surface proteins,
such as RIFIN and STEVOR, were similar in the parental
and SBP1KO parasites, suggesting that these surface anti-
gens are not dependent on SBP1. We also provided
evidence that RIFINs were exposed on the IE surface, by
showing that trypsin treatment of intact IEs led to degra-
dation of RIFINs. Furthermore, exported proteins required
for knob formation were still expressed by the SBP1KO
parasites. There is a possibility that the expression levels of
RIFINs and STEVORs may have changed in the SBP1KO
parasites compared to parental and this may contribute to
reduced antibody recognition. One previous study [58]
bFig. 5 Antibodies among pregnant women and men from PNG and
Malawi to surface antigens expressed by P. falciparum-IEs. a Among
PNG donors, IgG binding to the surface of erythrocytes infected with
CS2 SBP1KO parasites was markedly reduced compared to CS2
parental. Assays were performed twice independently; bars represent
median and interquartile ranges of samples tested in duplicate
(n = 94); p value was calculated using a paired Wilcoxon signed rank
test; IgG binding levels are expressed as geometric mean fluorescence
intensity (MFI) for all graphs. b A representative selection of samples
from PNG pregnant women tested for antibodies to CS2 parental and
CS2 SBP1KO. IgG binding to CS2 SBP1KO was substantially
reduced in most individuals. There was minimal background reactiv-
ity observed among sera from non-exposed Melbourne residents
(Control). Assays were performed twice independently; p value was
calculated using a paired Wilcoxon signed rank test; bars represent
mean and range of samples tested in duplicate. c. Serum samples from
pregnant women in PNG tested for antibodies to CS2 parental and
CS2 SBP1KO parasites are grouped by gravidity. Samples were from
malaria-exposed primigravid (PG; n = 33) and multigravid (MG;
n = 30) women and men (n = 31) in PNG. IgG binding to CS2
SBP1KO parasites was substantially reduced compared to CS2
parental in PG women, MG women and men. There was minimal
background reactivity observed among sera from non-exposed
Melbourne residents (Control). Assays were performed twice inde-
pendently; p value was calculated using a paired Wilcoxon signed
rank test; bars represent median and interquartile ranges of samples
tested in duplicate. d Rabbit antibodies (R1–R2) raised against the
DBL3 domain of VAR2CSA were tested for antibody recognition to
CS2 parental and CS2 SBP1KO. All samples showed a marked
reduction in IgG binding to CS2 SBP1KO. PI represents pre-immune
serum from these rabbits. Assays were performed twice indepen-
dently; bars represent mean and range of samples tested in duplicate.
e Among pregnant women from Malawi, IgG binding to the surface of
erythrocytes infected with CS2 SBP1KO parasites was markedly
reduced compared to CS2 parental. Assay was performed once; bars
represent median and interquartile ranges of samples tested in
duplicate (n = 81); p value was calculated using a paired Wilcoxon
signed rank test; IgG binding levels are expressed as geometric mean
fluorescence intensity (MFI) for all graphs. f A representative
selection of samples tested for antibodies to CS2 parental and CS2
SBP1KO. Samples were from malaria-exposed pregnant women from
Malawi (ML1–ML8) and non-exposed Melbourne residents (Con-
trol). IgG binding to CS2 SBP1KO was substantially reduced in most
individuals. There was minimal background reactivity observed
among sera from non-exposed Melbourne residents (Control). Assay
was performed once; p value was calculated using a paired Wilcoxon
signed rank test; bars represent mean and range of samples tested in
duplicate
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reported that a lower proportion of IEs stained positive
with STEVOR antibodies (raised against a STEVOR pep-
tide) for 3 lab isolates compared to 4 recently adapted
isolates. Currently we lack the tools to quantify the
expression of these other antigens on the IE surface of
parental and SBP1KO parasites, but there did not appear to
be a major difference in expression between parental and
KO parasites using western blots and immunofluorescence
microscopy, although these methods are not highly quan-
titative. Rapidly generating SBP1KO clones with clinical
isolates is currently not possible. It is unlikely that our
findings of reduced antibody recognition of SBP1KO IEs
can be explained by the switching of var genes and
PfEMP1 variants expressed between parental and SBP1KO
parasites as Northern blots showed bands of similar sizes in
both parental and SBP1KO parasites, and the disruption of
surface-exposed PfEMP1 has been confirmed in three
independent parasite isolates. Furthermore, the immune
serum used in our assays is not variant-specific and should
detect a wide repertoire of PfEMP1 variants, should they be
expressed by the SBP1KO parasites. In addition, previous
studies have been unable to select the SBP1KO parasites
for adhesion to immobilized receptors, thus suggesting that
the parasites have not switched to another PfEMP1 variant
[20, 21].
These findings have important translational implications
for understanding and measuring immunity, and develop-

































































































































































































































Fig. 6 Opsonic phagocytosis of
IEs by undifferentiated Thp-1
monocytes. Opsonic
phagocytosis activity of serum
antibodies from Kenya and
PNG was markedly reduced
with 3D7 SBP1KO (a) and E8B
SBP1KO (c, e) compared to
3D7 parental and E8B parental.
Assays were performed twice
independently; bars represent
median and interquartile ranges
[for Kenyan samples, n = 25
for 3D7 (a), n = 9 for E8B (b);
for PNG samples, n = 25 for
E8B (c)]; p value was calculated
using a paired Wilcoxon signed
rank test. For all graphs, the
level of opsonic phagocytosis is
expressed as a percentage of
positive control (rabbit antibody
raised against human
erythrocytes). A representative
selection of serum samples from
Kenya tested for opsonic
phagocytosis activity to 3D7
SBP1KO (b) and E8B SBP1KO
(d) and from PNG tested for
opsonic phagocytosis activity to
E8B SBP1KO (f). Assays were
performed twice independently
for 3D7 and once for E8B; bars
represent mean and range with
samples tested in duplicate
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the targets of mechanisms of immunity is crucial for the
development of effective vaccines, and our findings further
highlight the significance of PfEMP1 as the major target of
acquired human antibodies. While PfEMP1 is a known
target of immunity, it is important to quantify its role rel-
ative to other antigens in order to prioritize antigens for
vaccine development, and develop tools to quantify and
monitor human immunity, which are currently lacking.
There is significant interest in PfEMP1-based vaccines
[60–62] and vaccines based on the VAR2CSA-PfEMP1 are
progressing to clinical trials. We also demonstrate the
value of SBP1KO parasites as a tool to measure and
evaluate antibodies to surface antigens, particularly
PfEMP1, in populations and potentially in vaccine trials.
Unlike other tools, such as isolates with suppressed
PfEMP1 expression [15, 38], pfsbp1 gene-KO parasites are
phenotypically stable in culture and can be readily applied
in different assays and laboratories. Approaches to devel-
oping highly efficacious second generation vaccines
include the potential use of attenuated whole parasites,
including attenuated IEs [63, 64]. Therefore, it is important
to define key virulence features and antibody targets.
Moreover, our studies highlight a crucially important
evolutionary difference between P. falciparum and P.
vivax, which has major implications for understanding
immunity and disease pathogenesis and the development of
future vaccine and therapeutic strategies against these
pathogens.
In conclusion, our study has provided major new evi-
dence that the key targets of acquired human antibodies are
highly dependent on SBP1 for trafficking to the IE surface.
Moreover, finding that PfEMP1 is by far the major target of
human antibodies to the IE surface supports efforts to
develop vaccines based on this antigen. We also showed
that antibodies to SBP1-dependent antigens, predominantly
PfEMP1, play a key role in a mechanism of parasite
clearance by opsonizing IEs for phagocytosis. These find-
ings highlight an important role for SBP1 in the trafficking
of IE surface antigens and define a key feature in the
biology and virulence properties that may be different to
other human malarias. These findings have major impli-
cations for malaria vaccine development, and for
quantifying immunity in populations.
Methods
Study population and ethics statement
Serum samples (n = 100) were collected from a com-
munity-based cross-sectional study in the Madang
Province, PNG [65]. This population experiences year-
round malaria transmission with some seasonal variation
[66]. Half of these samples were from children with a
median age of 7 years (interquartile range, 6–9 years),
while the other half were from adults with a median age
of 28 years (interquartile range 24–35). For 9 subjects,
there was insufficient serum available for inclusion in this
study; therefore, a total of 91 subjects were included.
Serum samples were also collected from a cross-sectional
study of pregnant women in their second trimester
(n = 63) who visited the antenatal clinic for routine care,
and from men (n = 31), at the Yagaum Health Centre and
























































































Fig. 7 Opsonic phagocytosis of IEs by undifferentiated Thp-1
monocytes using sera from pregnant women in Malawi. Opsonic
phagocytosis activity was markedly reduced in CS2 SBP1KO
(a) compared to CS2 parental. Assays were performed twice
independently; bars represent median and interquartile ranges
(n = 36); p value was calculated using a paired Wilcoxon signed
rank test. For all graphs, the level of opsonic phagocytosis is
expressed as a percentage of positive control (rabbit antibody raised
against human erythrocytes). A representative selection of serum
samples tested for opsonic phagocytosis activity to CS2 SBP1KO (b).
Samples were from malaria-exposed pregnant women residing in
Malawi (ML9–19) and non-exposed Melbourne residents (Control).
Assays were performed twice independently; bars represent mean and
range with samples tested in duplicate
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previously described [67, 68]. Of these, 33 samples from
PGs and 30 samples from MG women were available for
testing. In Malawi, samples were collected from pregnant
women (n = 85) as described [69]. In Kenya, serum
samples (n = 25) were also collected from anonymous
adults at the Hospital Blood Donor Service in Kilifi, [15,
70] and from individuals participating in a longitudinal



































































































































Fig. 8 PfEMP1 is the major target of human antibodies. The overall
IgG binding to E8B SBP1KO parasites was markedly reduced
compared to E8B parental parasites and further reduced compared to
E8Bvpkd, among samples from PNG (a) and Kenya (c). Assays were
performed twice independently; bars represent median and interquar-
tile ranges (n = 12 for PNG, n = 7 for Kenya); p value was
calculated using a paired Wilcoxon signed rank test; IgG binding
levels are expressed as geometric mean fluorescence intensity (MFI)
for all graphs. A representative selection of samples tested in parallel
for antibodies to E8B parental, E8Bvpkd and E8B SBP1KO. Samples
were from malaria-exposed PNG adults (b; P7–P31), Kenyan adults
(d; K3–K18) and non-exposed Melbourne residents (Control). There
was minimal background reactivity observed among sera from
Melbourne residents. Assays were performed twice independently;
bars represent mean and range of samples tested in duplicate. e IgG
binding to the IE surface of 3D7 parental and 3D7vpkd was trypsin
sensitive compared to 3D7 SBP1KO. IEs were incubated with trypsin
at 5 or 10 ug/ml, or without trypsin, and tested for IgG reactivity
among samples form Kenyan adults. IgG binding levels are expressed
as a percentage of their respective 3D7 parental reactivity without
trypsin; bars represent mean and SEM of samples tested in duplicate
(n = 5) after subtraction with IgG levels from negative Melbourne
controls
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district as described elsewhere [15, 70, 71]. Ethics
approval was obtained from the Kenya Medical Research
Institute Ethics Committee, the Medical Research Advi-
sory Council PNG, the College of Medicine Research
Ethics Committee in Malawi, the Walter and Eliza Hall
Institute Human Research and Ethics Committee and the
Alfred Hospital Human Research and Ethics Committee.
Written informed consent was obtained from all study
participants or their parents or legal guardians.
Plasmodium falciparum culture and isolates
Plasmodium falciparum isolates were maintained in con-
tinuous culture and synchronized as previously described
[15]. Isolate E8B SBP1KO was generated by transfecting
E8B parental [27], derived from a clone of IT4, with the
pHHT-TK-DSBP1 plasmid and culturing in the presence of
WR99210 (2.5 nM), using established methods [72]. Iso-
lates 3D7 SBP1KO and CS2 SBP1KO were generated as
previously described [20, 21]. Isolates 3D7vpkd and
E8Bvpkd were generated as previously described [15, 38].
IEs were typically used in assays at the pigmented
trophozoite developmental stage when they express the
surface proteins PfEMP1, RIFIN, STEVOR, SURFIN
(except ring stage parasites were used for transcript anal-
ysis by northern blotting).
Measuring antibodies to the IE surface by flow
cytometry
Measuring IgG binding to the IE surface of pigmented
trophozoites was performed with an established flow
cytometry-based assay as previously described [15]. IgG
binding levels for each sample was expressed as the geo-
metric mean fluorescence intensity (MFI; arbitrary units)
for IEs, after subtracting the MFI of uninfected erythro-
cytes. Samples were tested at a 1/10 dilution and were
designated antibody positive if the MFI was greater than
the mean plus 3 standard deviation of reactivity seen with
sera from non-malaria exposed Australian residents. Cry-
opreserved pigmented trophozoite IEs used in antibody
assays have been previously validated (Beeson et al.
unpublished) [15, 73]. Cryopreservation of IEs was per-
formed as described [15]. IEs were incubated with various
concentrations of trypsin (0–10 lg/mL; TPCK-treated,
Worthington Biomedical) diluted in PBS for 15 min at
37 C, as previously described [15].
Western blots
Western blots of membrane proteins from pigmented
trophozoite-IEs were performed using Triton-X 100-in-
soluble, SDS-soluble protein extracts of pigmented
trophozoite-IEs as previously described [15]. Nitrocellu-
lose membranes (Invitrogen) were probed with affinity-
purified rat antibodies against recombinant RIF29 (1/2000)
[74, 75], rat antibodies against RIF40.2 (1/2000) [30],
affinity-purified mouse antibodies against recombinant
STEVOR3 protein (1/2000) [76], rabbit anti-SBP1 (1/
1000) [20], rabbit anti-HSP70 antibodies (1/500; provided
by Paul Gilson) and rabbit anti-aldolase (1/5000; provided
by Jake Baum). Magnet-purified IEs were incubated with
trypsin at 1 mg/mL (TPCK-treated, Sigma–Aldrich) or
PBS as a negative control for 30 min at 37 C, and the
reaction stopped with trypsin inhibitor (Sigma–Aldrich)
before the cells were extracted with SDS loading buffer, as
previously described [30].
Northern blots
RNA from highly synchronous ring-staged parasite cul-
tures at 10 h post-invasion was extracted using Trizol
(Invitrogen) as previously described [15]. Northern blots
were hybridized with a conserved var exon 2 sequence
(PlasmoDB accession number PFIT_1219000) and washed
at low stringency with 2X SSC and 0.1 % SDS at 55 C
[77].
Plasmodium falciparum cytoadherence assays
Testing for adhesion to immobilized receptors was per-
formed using gelatin-enriched pigmented trophozoite-IEs
at 15–20 % parasitemia as previously described [15]. The
numbers of bound cells were recorded as IEs per square
millimeter and PBS was used as a negative control to
record non-specific binding. Adhesion to each receptor was
tested in triplicate at these concentrations: ICAM-1 10 lg/
mL (Bender MedSystems) and CD36 20 lg/mL (rhCD36/
Fc chimera, R&D systems).
Immunofluorescence microscopy
Immunofluorescence microscopy of pigmented tropho-
zoite-IEs were performed as previously described [15].
Slides were incubated with primary antibodies such as anti-
ARIF40 (1/50; accession number AF483820) [75], anti-
STEVOR10 (1/200) [76], anti-SBP1 (1/500) [20], anti-
PfEMP3 (1/500; provided by Melanie Rug) and anti-
AMA1 (apical membrane antigen 1; 1/500) [78], followed
by the corresponding Alexa Fluor 488-conjugated IgG (1/
500, Invitrogen). Images were obtained using a Plan-
Apochromat (100 9/1.40) oil immersion phase-contrast
lens (Carl Zeiss) on an AxioVert 200 M microscope (Carl
Zeiss) equipped with an AxioCam Mrm camera (Carl
Zeiss).
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Opsonic phagocytosis assays
Measuring the level of opsonic phagocytosis activity using
undifferentiated Thp-1 monocytes was conducted as pre-
viously described [15, 36]. The proportion of Thp-1
positive cells with phagocytosed pigmented trophozoite-
IEs was counted by flow cytometry (FACSCalibur, BD
Biosciences). The level of phagocytosis for each sample
was expressed relative to the positive control (Abcam;
rabbit antibody raised against human erythrocytes). Nega-
tive control samples from non-malaria exposed Australian
residents were included in all assays. Purification of IgG
was performed using Melon Gel IgG purification kit
(Thermo Scientific) according to the manufacturer’s
instructions and dialysed into PBS prior to performing
antibody assays [79].
Scanning electron microscopy
Square glass coverslips (22 mm) were prepared by
smearing a 0.1 % solution of polyethyleneimine (PEI) and
dried. Pigmented trophozoite-IE samples were incubated
on PEI-coated glass coverslips for 30 min and then
immersed in 2 % glutaraldehyde in PBS for 1 h. Coverslips
were rinsed thrice in PBS for 10 min before being dehy-
drated in increasing concentrations of ethanol consisting of
10, 20, 40, 60, 80, and 100 % ethanol in water for 10 min
each. The coverslips were then dried in a Balzers CPD 030
Critical Point Dryer (Balzers Pfeiffer, Balzers, Liechten-
stein) and mounted onto 25 mm aluminum stubs with
double-sided carbon tabs and then gold-coated in a Dyna-
vac ‘‘Xenosput’’ magnetron sputter coater. Cells were
imaged with the Philips XL30 field emission scanning
electron microscope (Philips, Eindhoven, Netherlands) at a
voltage of 2 kV.
Statistical analyses
Non-parametric analytical methods were used to evaluate
assay results from cohort studies, as the data obtained were
not normally distributed. Differences in adhesion levels
between parental and genetically modified parasites were
assessed using an unpaired Mann–Whitney test. Differ-
ences in antibody levels between parental and genetically
modified parasites were assessed using a paired Wilcoxon
signed rank test or Kruskal–Wallis test ([2 groups). Sta-
tistical analyses were performed using Prism version 5
(GraphPad Software Inc) or Stata 12.0 (StataCorp).
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